P. aeruginosa is classified as a priority one pathogen by the World Health Organisation, and
new drugs are urgently needed, due to the emergence of multidrug-resistant (MDR) strains …

The global increase in multi-drug-resistant bacteria is severely impacting our ability to
effectively treat common infections. For Gram-negative bacteria, their intrinsic and acquired …

At present, anti-virulence drugs are being considered as potential therapeutic alternatives
and/or adjuvants to currently failing antibiotics. These drugs do not kill bacteria but inhibit …

Many clinical isolates of Pseudomonas aeruginosa cause infections that are difficult to
eradicate due to their resistance to a wide variety of antibiotics. Key genetic determinants of …

Emergence of epidemic clones and antibiotic resistance development compromises the
management of Pseudomonas aeruginosa cystic fibrosis (CF) chronic respiratory infections …

Pseudomonas aeruginosa is a Gram-negative bacterium causing diseases in plants,
animals, and humans, and its drug resistance is a major concern in medical care. Biofilms …

Nosocomial infection is a kind of infection, which is spread in various hospital environments,
and leads to many serious diseases (eg. pneumonia, urinary tract infection, gastroenteritis …

Pseudomonas aeruginosa is a notoriously difficult-to-treat pathogen that is a common cause
of severe nosocomial infections. Investigating a collection of β-lactam-resistant P …

Objective Pseudomonas aeruginosa is an opportunistic pathogen that infects the lungs of
people with cystic fibrosis (CF) and is the most common cause of chronic respiratory …

Pseudomonas is a bacterial genus, with a bona fide environmental habitat that comprises
different species, some of them causing diseases in humans and plants, as well as some …